BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 8876230)

  • 1. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.
    Dunbar CE; Seidel NE; Doren S; Sellers S; Cline AP; Metzger ME; Agricola BA; Donahue RE; Bodine DM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11871-6. PubMed ID: 8876230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
    Donahue RE; Kirby MR; Metzger ME; Agricola BA; Sellers SE; Cullis HM
    Blood; 1996 Feb; 87(4):1644-53. PubMed ID: 8608259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells.
    Hanenberg H; Hashino K; Konishi H; Hock RA; Kato I; Williams DA
    Hum Gene Ther; 1997 Dec; 8(18):2193-206. PubMed ID: 9449373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
    Prosper F; Stroncek D; Verfaillie CM
    Blood; 1996 Sep; 88(6):2033-42. PubMed ID: 8822922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates.
    Hematti P; Sellers SE; Agricola BA; Metzger ME; Donahue RE; Dunbar CE
    Blood; 2003 Mar; 101(6):2199-205. PubMed ID: 12424191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
    Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
    Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor.
    Tjønnfjord GE; Steen R; Evensen SA; Thorsby E; Egeland T
    Blood; 1994 Oct; 84(8):2795-801. PubMed ID: 7522643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow.
    Bodine DM; Seidel NE; Orlic D
    Blood; 1996 Jul; 88(1):89-97. PubMed ID: 8704206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor.
    Bodine DM; Seidel NE; Gale MS; Nienhuis AW; Orlic D
    Blood; 1994 Sep; 84(5):1482-91. PubMed ID: 7520774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.
    Hess DA; Levac KD; Karanu FN; Rosu-Myles M; White MJ; Gallacher L; Murdoch B; Keeney M; Ottowski P; Foley R; Chin-Yee I; Bhatia M
    Blood; 2002 Aug; 100(3):869-78. PubMed ID: 12130497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.
    Tisdale JF; Hanazono Y; Sellers SE; Agricola BA; Metzger ME; Donahue RE; Dunbar CE
    Blood; 1998 Aug; 92(4):1131-41. PubMed ID: 9694700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function.
    Dorrell C; Gan OI; Pereira DS; Hawley RG; Dick JE
    Blood; 2000 Jan; 95(1):102-10. PubMed ID: 10607692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables.
    Hennemann B; Conneally E; Pawliuk R; Leboulch P; Rose-John S; Reid D; Chuo JY; Humphries RK; Eaves CJ
    Exp Hematol; 1999 May; 27(5):817-25. PubMed ID: 10340397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice.
    Kollet O; Spiegel A; Peled A; Petit I; Byk T; Hershkoviz R; Guetta E; Barkai G; Nagler A; Lapidot T
    Blood; 2001 May; 97(10):3283-91. PubMed ID: 11342460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of transduced nonhuman primate CD34+ cells using a gibbon ape leukemia virus vector: restricted expression of the gibbon ape leukemia virus receptor to a subset of CD34+ cells.
    Bunnell BA; Kluge KA; Lee-Lin SQ; Byrne ER; Orlic D; Metzger ME; Agricola BA; Wersto RP; Bodine DM; Morgan RA; Donahue RE
    Gene Ther; 1999 Jan; 6(1):48-56. PubMed ID: 10341875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line.
    Nishi N; Ishikawa R; Inoue H; Nishikawa M; Kakeda M; Yoneya T; Tsumura H; Ohashi H; Yamaguchi Y; Motoki K; Sudo T; Mori KJ
    Exp Hematol; 1996 Sep; 24(11):1312-21. PubMed ID: 8862442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.